Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:announced |
2019
|
| gptkbp:ATCCode |
none
|
| gptkbp:CASNumber |
2226853-16-7
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:developedBy |
gptkb:Arvinas
|
| https://www.w3.org/2000/01/rdf-schema#label |
ARV-110
|
| gptkbp:indication |
metastatic castration-resistant prostate cancer
|
| gptkbp:intendedUse |
prostate cancer
|
| gptkbp:mechanismOfAction |
PROTAC protein degrader
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:synonym |
Bavdegalutamide
|
| gptkbp:target |
gptkb:androgen_receptor
|
| gptkbp:bfsParent |
gptkb:Arvinas
|
| gptkbp:bfsLayer |
7
|